Navigation Links
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Date:6/2/2008

NEW HAVEN, Conn., June 2 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that data from the Phase III trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in combination with cytarabine in patients with first relapse of acute myelogenous leukemia (AML) had been presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO(R)) in Chicago, Illinois.

The Phase III trial started in March 2005 and was conducted in 69 sites in North America and Europe. In May 2007, after an interim analysis of 210 patients by the trial's data safety monitoring board (DSMB), the Company suspended treatment and enrollment of patients, and the U.S. Food and Drug Administration (FDA) placed the trial on clinical hold, due to increased mortality in the cytarabine plus Cloretazine(R) (VNP40101M) treatment arm of the study, as compared to the cytarabine plus placebo control arm. In January 2008, the Company announced that the FDA had lifted the clinical hold and that a new trial with a lower dose of Cloretazine(R) (VNP40101M) in combination with cytarabine and increased supportive care measures could be pursued in the future.

The objective response rate of the cytarabine and Cloretazine(R) (VNP40101M) treatment arm of the trial was 37% versus 19% for the control arm. The median response duration was 11.2 months on the treatment arm versus 8.1 months on the control arm. Overall survival was 4.2 months on the treatment arm versus 6 months on the control arm.

The Company reported that on-study mortality (deaths from all causes in less than or equal to 30 days or from adverse events in less than or equal to 60 days from any treatment cycle) was 39% for the cytarabine and Cloretazin
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 Aultman Hospital in ... (WCA) to transition its outpatient wound center electronic ... commitment to the specialty of wound care by ... country currently working with Wound Care Advantage ... wound care treatments and hyperbaric oxygen therapy to ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Consolidated ... are moving forward nationwide, as courts overseeing proceedings ... next month. According to court documents issued in ... the next status conference in the federal Xarelto ... 9:00 a.m. C.S.T. (In Re: Xarelto Products ...
(Date:4/28/2015)... Seton Hall University Provost Larry A. Robinson has ... Dean of Seton Hall School of Law. She will begin ... Boozang, currently Associate Dean for Academic Advancement and Professor of ... launch and currently directs the school’s prestigious Center for ... 10 law health program by U.S. News & World Report ...
(Date:4/28/2015)... 2015 April 8th, 2015, saw ... “RockNRolla Movie Awards” EcoLuxe Lounge, with Choices Recovery ... Entertainment, Los Angeles’ leading producer of sustainable product ... force behind this event, which featured some of ... conscious products and services. The EcoLuxe Lounge is ...
(Date:4/28/2015)... April 28, 2015 Children’s Medical ... the cause of medical foods and formulas through ... as the organization’s new executive director. , Thousands ... health consequences because of conditions and diseases that ... diet. To live and thrive, they are ...
Breaking Medicine News(10 mins):Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 2Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 3Health News:Choices Recovery South Bend Examines Support Systems in Treatment with Hollywood's Mike Pericoloso 2Health News:Children's Medical Nutrition Alliance (CMNuA) Hires Kaycee Childress as Executive Director 2
... March 23 Master,s and doctoral degree ... Carolina public and private colleges and universities may ... for the 2010-11 academic year at the college information ... for the coming year, according to the North Carolina ...
... teleconference is just as effective as face-to-face sessions, according ... professor at the Universit de Montral. "Previous ... just as efficient as face to face contact," says ... Studies Centre at the Louis-H. Lafontaine Hospital,s Fernand-Seguin Research ...
... protein changes in the blood linked to alcohol use may ... currently available, according to Penn State College of Medicine researchers. ... substance abuse -- things like cocaine or heroin or PCP ... those over 21," said Willard M. Freeman, Ph.D., department of ...
... ... replacement, may be an appropriate first step for many people with knee joint arthritis ... the long-term feasibility of artificial knee replacement. , ... San Francisco, CA (PRWEB) March 22, 2010 -- Biologic ...
... Toys“R”Us, ... in April Activities , ... New York, NY (PRWEB) March 23, 2010 -- Autism Speaks ... awareness and fundraising initiatives involving a range of corporate and philanthropic partners that will ...
... that replacing saturated fats has heart benefits , ... with polyunsaturated fats may reduce your risk of heart ... Health researchers reviewed eight studies with a total of ... fats in their diet with polyunsaturated fats had a ...
Cached Medicine News:Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 2Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 3Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 4Health News:Therapy via teleconference? 2Health News:Proteins may point to alcohol use test 2Health News:Proteins may point to alcohol use test 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 2Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 3Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 4Health News:Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis 5Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 2Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 3Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 4Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 5Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 6Health News:Autism Speaks Celebrates Autism Awareness Month With a Series of National Awareness and Fundraising Initiatives 7Health News:Polyunsaturated Fats Really May Lower Heart Risk 2
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... 28, 2015 The pharmacy information ... million by 2019, growing at a CAGR of 7.7% ... TOC of the pharmacy information systems market, to get ... provides a glimpse of the segmentation of pharmacy information ... by various tables and figures. http://www.micromarketmonitor.com/market-report/pharmacy-information-system-reports-2473565504.html ...
(Date:4/28/2015)... MAHWAH, N.J. , April 28, 2015 ... Tour," Stryker Orthopaedics, is kicking off tournament week by ... the second consecutive year appearing at the tournament, Stryker ... fans about the importance of joint health and mobility. ... Woodlands , Stryker is bringing new features to ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 2Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 2The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 4
The Shandon Manual Staining Station is ideal for special processes, frozen sections, special stains and low volume procedures....
The Shandon Finesse 315 low-cost precision microtome is ergonomically designed to consistently produce high quality routine paraffin sections without user strain or fatigue....
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor....
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
Medicine Products: